Point72 Hong Kong’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-958
Closed -$69K 2442
2022
Q2
$69K Buy
+958
New +$71.3K ﹤0.01% 1285
2022
Q1
Sell
-321
Closed -$32K 2341
2021
Q4
$32K Sell
321
-167
-34% -$16.7K ﹤0.01% 1459
2021
Q3
$45K Buy
488
+405
+488% +$39K ﹤0.01% 1548
2021
Q2
$9K Sell
83
-212
-72% -$21.3K ﹤0.01% 1752
2021
Q1
$29K Buy
+295
New +$26.8K ﹤0.01% 1403
2020
Q4
Sell
-402
Closed -$30K 2061
2020
Q3
$30K Buy
+402
New +$32.3K ﹤0.01% 785
2019
Q3
Sell
-174
Closed -$14K 1364
2019
Q2
$14K Buy
+174
New +$13.8K ﹤0.01% 828
2018
Q4
Sell
-326
Closed -$39K 1215
2018
Q3
$39K Buy
326
+137
+72% +$17K 0.01% 504
2018
Q2
$22K Buy
189
+149
+373% +$16.3K 0.01% 567
2018
Q1
$3K Buy
+40
New +$3.1K ﹤0.01% 768
2017
Q4
Sell
-260
Closed -$15K 1108
2017
Q3
$15K Buy
+260
New +$15.4K 0.01% 436
2017
Q1
Sell
-2,162
Closed -$132K 1001
2016
Q4
$132K Buy
+2,162
New +$141K 0.13% 199

Other funds holding USNA

Point72 Hong Kong's USNA Position: Q3 2022 in Review

Point72 Hong Kong sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 958 shares — an estimated $69K sold.

Point72 Hong Kong first reported a position in USNA in Q4 2016 and held it in 12 quarters. The position peaked at $132K in Q4 2016. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.

  • Point72 Hong Kong reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 958 Usana Health Sciences shares in Q3 2022, an estimated $69K.
  • Point72 Hong Kong first reported a position in Usana Health Sciences in Q4 2016 and held it in 12 quarters.
  • Point72 Hong Kong's Usana Health Sciences position peaked at $132K in Q4 2016.
  • 172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.